ASGCT 15th Annual Meeting General Evaluation

Meeting Objectives:

At the conclusion of the activity, the participant should be able to:
  • Provide advice to patients who inquire about the potential of gene and cell therapy or the availability of open clinical trials, based on their exposure to the current clinical trials in gene and cell therapies.
  • Review state-of-the-art basic science and clinical trials data presented at this meeting with students in medical school and other health venues.
  • Use the latest advances in gene and cell therapy to enhance their research mission, as physician scientists conducting basic and clinical research.
  • Demonstrate improved regulatory compliance in conducting gene and cell therapy clinical trials, through exposure to NIH and FDA faculty during the educational program.

Question Title

* 1. Please answer the following:

  Excellent Good Average Poor Very Poor Not Sure or N/A
The meeting met the stated objectives above
Relevancy of the meeting to the study of gene and/or cell therapy
Methods used by researchers
Access to faculty and presenters
Quality of Wednesday education programs
Quality of Scientific Symposia
Presentation of oral abstracts
Topics of poster sessions
Visual appearance of posters at poster sessions
Exhibitor products and services displayed at meeting
Exhibitor hours available to attendees
Online Preliminary Program
Final Program
ASGCT registration process
Pennsylvania Convention Center facilities
Abstract submission process
Helpfulness of Job Exchange area

Question Title

* 2. Were you informed of any potential conflict of interest regarding all individuals in the position to control the content of this Educational activity?

Question Title

* 3. Prior to the meeting, did you access the ASGCT Website for meeting information?

Question Title

* 4. Did you find the Website useful?

Question Title

* 5. What changes would you suggest for the future to make the ASGCT Annual Meeting more beneficial and useful to you?

Question Title

* 6. What topics would you like to see addressed at future ASGCT meetings?

Question Title

* 7. Other Comments:

T